7-azaindole as privileged scaffold: Advances in drug design and structural modification
Medicinal Chemistry Research · 2026-08 · 35 (8) · 1414-1453
DOI: 10.1007/s00044-026-03597-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Chemistry Research, online erschienen am 23.07.2026. Verfasst von Yichun Shi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, West Chi…. Hauptthemen laut MEDLINE: Indoles, Drug Design, Protein Kinase Inhibitors. Die Arbeit nennt 154 Literaturangaben.
Abstract (Originalsprache)
7-azaindole is a nitrogen-containing heterocycle derived from indole, which has emerged as a privileged scaffold in drug design owing to its unique electronic distribution, spatial conformation, and dual-site hydrogen-bonding pharmacophore. Compared with indole, it exhibits enhanced hydrogen-bonding capacity, improved stability, and metabolic tolerance, while also allowing facile optimization of solubility, selectivity, and pharmacokinetic (PK) properties. Consequently, the 7-azaindole scaffold has been widely employed in the development of kinase inhibitors, anti-inflammatory agents, and neuro-modulatory agents. Approved drugs such as vemurafenib, pexidartinib, and venetoclax exemplify its successful translation from fragment to drug. This review comprehensively summarizes medicinal chemistry advances based on the 7-azaindole scaffold from 2020 to 2026, and critically consolidates SAR trends, pinpoints the most frequently successful substitution vectors, and dissects recent clinical failures. It aims to provide a reference for the future development of novel 7-azaindole-based therapeutics. The 7 azaindole has emerged as a privileged scaffold in drug design. The review surveys the applications of 7 azaindole-based compounds from 2020 to 2026. The review focuses on SAR trends, druggability optimization, and biological activities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, West China School of Pharmacy, Sichuan University, Chengdu, 610041, China.
- Institute of Materials, China Academy of Engineering Physics, Jiangyou, Mianyang, Sichuan, 621907, China.
- 903 Hospital, Jiangyou, Mianyang, Sichuan, 621700, China.
- Institute of Materials, China Academy of Engineering Physics, Jiangyou, Mianyang, Sichuan, 621907, China. 2636445975@qq.com.
Zitieren
APA
Shi, Y., Yu, G., Xu, Y., & Liao, X. (2026). 7-azaindole as privileged scaffold: Advances in drug design and structural modification. Medicinal Chemistry Research, 35(8), 1414-1453. https://doi.org/10.1007/s00044-026-03597-4
Vancouver
Shi Y, Yu G, Xu Y, Liao X. 7-azaindole as privileged scaffold: Advances in drug design and structural modification. Medicinal Chemistry Research. 2026;35(8):1414-1453. doi:10.1007/s00044-026-03597-4
BibTeX
@article{Shi2026,
author = {Shi, Yichun and Yu, Guangjun and Xu, Yidan and Liao, Xindan},
title = {7-azaindole as privileged scaffold: Advances in drug design and structural modification},
journal = {Medicinal Chemistry Research},
year = {2026},
volume = {35},
number = {8},
pages = {1414--1453},
doi = {10.1007/s00044-026-03597-4}
}
EUVIMED